Business NewsPR NewsWire • New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease

New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease

New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease

INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data showing that beta-amyloid imaging was associated with altered diagnosis and management of patients with Alzheimer's disease. Change in management  was observed in both patients...

View More : http://www.prnewswire.com/news-releases/new-study-shows-beta-amyloid-imaging-is-associated-with-altered-diagnosis-and-ma...
Releted News by prnewswire
Eclipse is First to Market With New ID & AML Check
New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease
Leju Launches Mobile E-commerce Platform 2.0
Toastmasters Reveals 2014 International Convention Speakers